Free Trial

35,700 Shares in Select Medical Holdings Co. (NYSE:SEM) Acquired by Versor Investments LP

Select Medical logo with Medical background

Versor Investments LP purchased a new position in shares of Select Medical Holdings Co. (NYSE:SEM - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 35,700 shares of the health services provider's stock, valued at approximately $1,245,000.

Several other large investors have also recently added to or reduced their stakes in the company. Price T Rowe Associates Inc. MD increased its stake in Select Medical by 0.5% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 17,202,219 shares of the health services provider's stock worth $518,647,000 after purchasing an additional 90,604 shares in the last quarter. Vanguard Group Inc. increased its position in shares of Select Medical by 5.3% during the first quarter. Vanguard Group Inc. now owns 12,997,891 shares of the health services provider's stock valued at $391,886,000 after purchasing an additional 650,093 shares during the period. Dimensional Fund Advisors LP grew its position in Select Medical by 2.2% in the second quarter. Dimensional Fund Advisors LP now owns 4,498,772 shares of the health services provider's stock valued at $157,728,000 after acquiring an additional 95,578 shares during the period. Principal Financial Group Inc. boosted its stake in Select Medical by 6.7% in the third quarter. Principal Financial Group Inc. now owns 2,357,823 shares of the health services provider's stock worth $82,208,000 after purchasing an additional 147,032 shares in the last quarter. Finally, Point72 Asset Management L.P. boosted its stake in Select Medical by 179.5% in the second quarter. Point72 Asset Management L.P. now owns 843,528 shares of the health services provider's stock worth $29,574,000 after purchasing an additional 541,728 shares in the last quarter. 89.48% of the stock is currently owned by institutional investors.

Select Medical Stock Performance

NYSE SEM traded down $1.02 on Tuesday, hitting $39.18. 651,631 shares of the stock traded hands, compared to its average volume of 608,589. The business's fifty day moving average is $34.56 and its two-hundred day moving average is $34.53. Select Medical Holdings Co. has a 12 month low of $21.56 and a 12 month high of $40.98. The firm has a market capitalization of $5.07 billion, a price-to-earnings ratio of 18.40, a PEG ratio of 2.04 and a beta of 1.42. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13.

Select Medical (NYSE:SEM - Get Free Report) last posted its quarterly earnings data on Thursday, October 31st. The health services provider reported $0.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.07. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The company had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.74 billion. During the same quarter last year, the company earned $0.46 earnings per share. The firm's quarterly revenue was up 5.7% on a year-over-year basis. As a group, equities analysts anticipate that Select Medical Holdings Co. will post 2.16 EPS for the current fiscal year.

Select Medical Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 26th. Stockholders of record on Wednesday, November 13th will be issued a $0.125 dividend. The ex-dividend date is Wednesday, November 13th. This represents a $0.50 annualized dividend and a dividend yield of 1.28%. Select Medical's dividend payout ratio is currently 23.36%.

Wall Street Analyst Weigh In

Several brokerages have issued reports on SEM. Bank of America began coverage on Select Medical in a report on Tuesday, August 20th. They issued a "buy" rating and a $42.00 price target for the company. Benchmark reaffirmed a "buy" rating and issued a $48.00 price objective on shares of Select Medical in a research report on Friday, November 1st. StockNews.com cut Select Medical from a "buy" rating to a "hold" rating in a report on Tuesday, November 5th. Finally, Royal Bank of Canada raised their price objective on Select Medical from $40.00 to $47.00 and gave the stock an "outperform" rating in a research note on Monday, November 4th. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. According to data from MarketBeat, Select Medical currently has an average rating of "Moderate Buy" and an average price target of $40.75.

Check Out Our Latest Report on Select Medical

Select Medical Profile

(Free Report)

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

See Also

Institutional Ownership by Quarter for Select Medical (NYSE:SEM)

Should you invest $1,000 in Select Medical right now?

Before you consider Select Medical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Select Medical wasn't on the list.

While Select Medical currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for December 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines